Array ( [1576123952] => Array ( [wordfence_hourly_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1576125573] => Array ( [wp_privacy_delete_old_export_files] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1576126081] => Array ( [wpm_update_stats] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1576133753] => Array ( [publish_future_post] => Array ( [8f1de180269d63fa18bf9a2ce0546e52] => Array ( [schedule] => [args] => Array ( [0] => 479961 ) ) ) ) [1576134512] => Array ( [ai1wm_storage_cleanup] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576140571] => Array ( [wp_scheduled_auto_draft_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576145711] => Array ( [delete_expired_transients] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576145752] => Array ( [wpseo-reindex-links] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576152752] => Array ( [wordfence_daily_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576157526] => Array ( [wp_update_themes] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_version_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_update_plugins] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1576158274] => Array ( [wp_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576163873] => Array ( [wp_session_garbage_collection] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1576166824] => Array ( [akismet_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576169811] => Array ( [yoast_tracking] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1576244999] => Array ( [wordfence_start_scheduled_scan] => Array ( [44d43aa69033fca61c02407c6c65d4d4] => Array ( [schedule] => [args] => Array ( [0] => 1576244999 ) ) ) ) [1576504199] => Array ( [wordfence_start_scheduled_scan] => Array ( [ccee4635eaa1c5c68847742cf6f56334] => Array ( [schedule] => [args] => Array ( [0] => 1576504199 ) ) ) ) [1576508400] => Array ( [wordfence_email_activity_report] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => [args] => Array ( ) ) ) ) [1580169600] => Array ( [publish_future_post] => Array ( [2d492587fa52e9c78f7043ddf937b0a1] => Array ( [schedule] => [args] => Array ( [0] => 18611 ) ) [dea3edad73162f380bc9dc44fa3407bf] => Array ( [schedule] => [args] => Array ( [0] => 19670 ) ) [2caa9c58a241c4f77a6856802c1b43fb] => Array ( [schedule] => [args] => Array ( [0] => 20734 ) ) [307b37ba29b8cd716eafa809661756e3] => Array ( [schedule] => [args] => Array ( [0] => 22852 ) ) [365be9eba8e62abb0c0d4bfe013a2687] => Array ( [schedule] => [args] => Array ( [0] => 23918 ) ) [0e942b20ffb9550322105263ad82126f] => Array ( [schedule] => [args] => Array ( [0] => 24977 ) ) [661c5eb39689fe2133ff7986ac6628fb] => Array ( [schedule] => [args] => Array ( [0] => 26036 ) ) [75562b264e355915e4dea97042a28f7e] => Array ( [schedule] => [args] => Array ( [0] => 27095 ) ) [11cf4e8a6f842b0115881551a29c47f6] => Array ( [schedule] => [args] => Array ( [0] => 28154 ) ) [55a38aaca11da398c854cb29a7d4f5e6] => Array ( [schedule] => [args] => Array ( [0] => 30272 ) ) [f8cbc904676c235c7057ec965c01c023] => Array ( [schedule] => [args] => Array ( [0] => 32390 ) ) ) ) [1583794819] => Array ( [publish_future_post] => Array ( [9d993985746691420cd7524448c48a23] => Array ( [schedule] => [args] => Array ( [0] => 448880 ) ) ) ) [1601157627] => Array ( [publish_future_post] => Array ( [aa3f9c41dd8e97586795881a0c603b8d] => Array ( [schedule] => [args] => Array ( [0] => 472787 ) ) ) ) )
Etiquetas: 24 mayo 2011, 24/05/2011, BOE, Boletín Oficial del Estado, Cáncer, Carlos III, Centro Nacional de Investigaciones Oncológicas, Ciencia, CNIC, CNIO, Congreso de los Diputados, Consejo General de Ciencia y Tecnología, Financiación, Fundación CIEN, Imprenta Nacional BOE, innovación, Instituto de Salud Carlos III, Ley, Ley de Economía Sostenible, Madrid, MICINN, Ministerio de Ciencia e Innovación, Programa de terapias experimentales, Proyectos de investigación, salud, Sanidad, Sistema Nacional de Salud, tecnología.
Etiquetas: 20 septiembre 2011, 20/09/2011, Alzheimer, Asociación Española contra el Cáncer, Cáncer, Cancer Institute de Boston, Centro Nacional de Investigaciones Oncológicas, CNIO, Comisión de Ciencia e Innovación, Congreso de los Diputados, Enfermedades, Felipe Petriz, Guerra contra el cáncer, Hospital de Fuenlabrada, Investigación contra el cáncer, Lilly, Madrid, Manuel Hidalgo, Mikel Bishop, Organismos públicos de investigación, Programas de investigación, salud, Sanidad.
Etiquetas: 08/01/2008, 8 Enero 2008, Acción Estratégica de Salud del Plan Nacional de I+D+i 2008-2011, Acciones Estratégicas mediante la firma de Convenios, Agencia Estatal de Investigación en Biomedicina y Ciencias de la Salud, Antonio Campos, CAIBER, CCAA, Centro Nacional de Investigaciones Cardiovasculares, Centro Nacional de Investigaciones Oncológicas, Centros de atención primaria, Centros de Investigación Biomédica en Red, CIBER, CNIC, CNIO, Conjunto de Acciones Concertadas en Investigación Biomédica, Enfermedades de elevada prevalencia, Estructuras Estables de Investigación, FIS, Flora de Pablo, Fondo de Investigación Sanitaria, Fondos Estructurales, Francisco Gracia, grandes Complejos Sanitarios, Hospitales, Incremento presupuestario, Industria farmacéutica, Instituciones sanitarias, Instituto de la Salud Carlos III, Inversión pública en I+D, Investigación biomédica, Investigación en Medicina Regenerativa, José Antonio Gutiérrez, José Borrell, José Ramón Ricoy, Ley de Investigación Biomédica, Línea política prioritaria, Madrid, Ministerio de Sanidad y Consumo, Ministro, Nuevas tecnologías, Palabras, Política de investigación sanitaria, Problemas estratégicos, Profesionales sanitarios, Programa INGENIO 2010, Programa Marco de la Unión Europea, Programas de Investigación Cooperativa en Red, Rafael Nájera, Redes Temáticas de Investigación Cooperativa, Registro Nacional de Biobancos para Investigación Biomédica, RETICs, salud, Sanidad, Sanidad y consumo, Sistema Nacional de Salud, SNS, Vigésimo aniversario, XX aniversario.
Utilizamos cookies propias y de terceros para recopilar información que ayuda a optimizar su visita. Las cookies no se utilizan para recoger información de carácter personal. Usted puede permitir su uso o rechazarlo, también puede cambiar su configuración siempre que lo desee. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.
x